Expression of angiogenic factors in juvenile rheumatoid arthritis: Correlation with revascularization of human synovium engrafted into SCID mice

Arthritis and Rheumatism

Volumn 44, Issue 4, 2001, Pages 794-801

  Scola, Michael P ^a   Imagawa, Tomoyuki ^a   Boivin, Gregory P ^a   Giannini, Edward H ^a   Glass, David N ^b   Hirsch, Raphael ^a   Grom, Alexei A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ENDOGLIN; MESSENGER RNA; THROMBIN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE RHEUMATOID ARTHRITIS; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIUM;

ANGIOPOIETIN-1; ANIMALS; ANTIGENS, CD; ARTHRITIS, JUVENILE RHEUMATOID; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN; RNA, MESSENGER; SYNOVIAL MEMBRANE; TISSUE TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035052487     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200104)44:4<794::AID-ANR135>3.0.CO;2-7     Document Type: Article

References (40)

1. Rheumatoid arthritis: Pathophysiology and implications for therapy
2. Juvenile rheumatoid arthritis
3. Immunological aspects of rheumatoid synovium
4. Light-and electron-microscopic findings of juvenile rheumatoid arthritis synovium: Comparison with normal juvenile synovium
5. Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: Proposals for the evaluation of tissue samples by quantitative analysis
6. Pathogenesis of joint damage in rheumatoid arthritis
7. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis
8. Angiogenesis in cancer, vascular, rheumatoid and other disease
9. Angiogenesis: A critical process in the pathogenesis of RA - A role for VEGF?
10. Angiogenesis: Implications for rheumatoid arthritis
11. Angiogenesis inhibition suppresses collagen arthritis
12. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
13. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
14. Vascular permeability factor/endothelial growth factor: Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
15. Expression of basic fibroblast growth factor in synovial tissues from patients with rheumatoid arthritis: Detection by immunohistological staining and in situ hybridization
16. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease
17. Expression of basic fibroblast growth factor and angiogenin in arthritis
18. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
19. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
20. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
21. CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor
22. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor a and interleukin-1 in rheumatoid arthritis
23. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
24. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
25. New vessels, new approaches: Angiogenesis as a therapeutic target in musculoskeletal disorders
26. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis
27. Engraftment of human synovium into severe combined immune deficient mice: Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes
28. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice
29. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective
30. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo
31. Vascular specific growth factors and blood vessel formation
32. Increased vascularization in mice overexpressing angiopoietinol
33. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
34. Defective angiogenesis in mice lacking endoglin
35. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
36. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis
37. Histologic features of rheumatoid synovium in the SCID mouse-human RA model
38. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
39. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
40. Tissue cytokine patterns distinguish variants of rheumatoid synovitis